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ABSTRACT
Coronaviruses RNA synthesis occurs in the cyto-
plasm and is regulated by host cell proteins. In
a screen based on a yeast three-hybrid system
using the 50-untranslated region (50-UTR) of SARS
coronavirus (SARS-CoV) RNA as bait against a
human cDNA library derived from HeLa cells, we
found a positive candidate cellular protein, zinc
finger CCHC-type and RNA-binding motif 1
(MADP1), to be able to interact with this region of
the SARS-CoV genome. This interaction was subse-
quently confirmed in coronavirus infectious
bronchitis virus (IBV). The specificity of the inter-
action between MADP1 and the 50-UTR of IBV was
investigated and confirmed by using an RNA
pull-down assay. The RNA-binding domain was
mapped to the N-terminal region of MADP1 and
the protein binding sequence to stem–loop I of IBV
50-UTR. MADP1 was found to be translocated to the
cytoplasm and partially co-localized with the viral
replicase/transcriptase complexes (RTCs) in IBV-
infected cells, deviating from its usual nuclear
localization in a normal cell using indirect immuno-
fluorescence. Using small interfering RNA (siRNA)
against MADP1, defective viral RNA synthesis
was observed in the knockdown cells, therefore
indicating the importance of the protein in coron-
aviral RNA synthesis.
INTRODUCTION
During the replication of mammalian viruses, it is inevit-
able for host proteins to be involved in the viral life cycles.
In fact, coronaviruses require host proteins to aid in the
stages from virus entry to progeny release. Entry of the
virus particle into a host cell requires the recognition of
speciﬁc cell surface proteins, which act as receptors for the
virus spike (S) protein (1–6). Upon entry into host cells,
the ribonucleocapsid uncoats and releases the 50-capped
viral genome, a single-stranded positive-sense RNA.
The genomic RNA ranges from 27 to 32kb in length, is
the largest known of its kind and is structurally similar to
host mRNA (7). The replicase gene, which spans the 50
two-thirds of the genome, is translated by host ribosomes
into two large polyproteins, pp1a and pp1ab via a frame-
shift event (8–10). The polyproteins are autoproteo-
lytically processed into a maximum of 16 nonstructural
proteins (8,11–16), which are assembled into replication–
transcription complexes, including the main enzyme
RNA-dependent RNA polymerase (nsp12) (17,18). This
complex is required for generating new full-length virus
RNA in replication as well as subgenome-length RNAs
to be used for translation of virus structural and accessory
proteins. In addition to their role in RNA synthesis, these
nonstructural proteins may have multiple functions, such
as the suppression of host mRNA translation as well as
mRNA degradation by nsp1 of SARS coronavirus
(SARS-CoV; 19–21), which may play a role in the sup-
pression of immune response mounted by the host upon
infection.
The replication–transcription complex (RTC), which is
located on membrane bound vesicles in the cytoplasm
(22), is required for genome replication through continu-
ous transcription and subgenomic RNA synthesis via dis-
continuous transcription (18,23,24). Apart from the
replicase gene products, a viral structural protein, the
nucleocapsid (N), is also required for efﬁcient viral RNA
synthesis (25,26). The resulting genome-size transcripts are
destined to be packaged into progeny virions while the
subgenomic, positive-sense transcripts are being translated
into four structural proteins, spike (S), nucleocapsid (N),
membrane (M) and envelope (E) proteins, as well as other
accessory proteins.
In virus RNA synthesis, the replicase complex is indis-
pensable but not an exclusive participant. Several host
proteins have been identiﬁed to be able to interact with
regulatory signals within the untranslated regions in the
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polypyrimidine tract-binding protein (PTB) (27,28) with
the leader sequence, hnRNP A1 (27,29,30) and hnRNP
Q (31) with the 30-UTR. More recently, poly(A)-binding
protein (PABP), hnRNP Q and glutamyl-prolyl-tRNA
synthetase (EPRS) were found to play a role in corona-
virus RNA synthesis through their interaction with the
30-UTR of alphacoronavirus TGEV (32). In addition,
interaction of viral proteins with host proteins, such as
the recently identiﬁed interaction between coronavirus
nsp14 and DDX1 (33), may also play important enhance-
ment functions in coronavirus replication and infection
cycles.
In this study, we describe the interaction of a cellular
protein, MADP1 (zinc ﬁnger CCHC-type and RNA
binding motif 1) with the 50-UTR of IBV and SARS-
CoV, using yeast-based three hybrid screen (34) and
RNA-binding assays. Subsequently, the RNA-binding
domain of MADP1 and the RNA secondary structure re-
sponsible for the interaction were mapped and deﬁned.
Using indirect immunoﬂuorescence, we conﬁrmed that
MADP1, despite being reported as a nuclear protein
(35), was detected in the cytoplasm of virus-infected cells
and partially co-localized with the RTCs. Upon silencing
of MADP1 using siRNA, viral RNA synthesis on general
has been affected, resulting in a lower replication efﬁ-
ciency and infectivity.
MATERIALS AND METHODS
Over-expression of Flag-tagged proteins
All wild-type and mutant MADP1 expressing constructs
were based on the vector pXJ40Flag which contains both
the CMV and T7 promoter and all expressed proteins
were N-terminally tagged with the Flag epitope. For the
over-expression of the wild-type and mutant MADP1
proteins, H1299 cells grown to 100% conﬂuency were
infected with recombinant Vaccinia-T7 virus for 2h (h),
and the constructs were transfected into the infected cells
using Effectene Transfection Reagent (Qiagen). Cells were
lysed with lysis buffer [140mM NaCl, 10mM Tris
(pH 8.0), 1% NP-40] 22h post-transfection.
Biotin-RNA pull-down assay
Template DNA was ampliﬁed from plasmid DNA
encoding the 50 end of IBV genome with various sets of
primers targeting different regions of the 50-UTR (Tables 1
and 2), with the sense primers containing the T7 promoter
sequence (36). Biotinylated RNAs were in vitro transcribed
with T7 RNA polymerase (Roche Applied Science) in the
presence of Biotin RNA Labeling Mix (Roche Applied
Science) at 37 C for 2h. Template DNAs were removed
by digestion with RNase-free DNase I (Roche Applied
Science) and the labeled RNAs puriﬁed with UltraPure
Phenol:Chloroform:Isoamyl Alcohol (Invitrogen) then
solubilized in nuclease-free water.
Biotinylated RNA at 0.1mM was incubated with cell
lysates over-expressing EGFP, Flag-tagged MADP1 or
its mutant proteins, respectively, in the presence of
10mM dithiothreitol (DTT), 100mg/ml yeast tRNA
(Ambion) and 1U/ml Protector RNase Inhibitor (Roche
Applied Science) in a ﬁnal volume of 200ml at room tem-
perature for 30min. The mixtures were incubated with
40ml (50% slurry) of streptavidin agarose beads (Sigma
Aldrich) at room temperature for 30min. The beads
were collected by centrifugation and washed three times
with RNase P (RP) buffer (50mM KCl, 1mM MgCl2,
10mM HEPES, pH 8.0), suspended in 25ml of sodium
dodecyl sulfate (SDS) sample buffer with 100mM DTT.
Bound proteins were resolved by SDS–polyacrylamide gel
electrophoresis (SDS–PAGE) and detected with appropri-
ate antibodies.
Indirect immunoﬂuorescence microscopy and
bromo-UTP labeling
African green monkey kidney cells (Vero) grown to 50%
conﬂuency in four-chamber glass slides were transfected to
over-express Flag-tagged MADP1 or vector control using
Effectene for 16h. Transfected cells were infected with
wild-type IBV or mock-infected with Vero cell lysate
(Vero cells with serum-free medium subjected to three
freeze–thaw cycles at minus 80 C and room temperature,
respectively) for 1h. Infection was allowed to progress for
2h after virus removal and the cells were treated with
actinomycin D at 15mg/ml (Sigma Aldrich) for 4h;
1mM of BrUTP (Sigma Aldrich) was transfected into
the cells with SuperFECT (Qiagen) for 3h.
Cells were ﬁxed at 10h post-infection with 4%
paraformaldehyde for 15min and permeabilized
with 0.2% Triton-X 100 for 10min. Treated cells were
blocked in 10% goat serum, stained with primary
antibodies mouse anti-BrdU and rabbit anti-Flag (Sigma
Aldrich) and subsequently probed with AlexaFluor 488
anti-rabbit and 594 anti-mouse (Invitrogen) antibodies.
Images were captured with Olympus Fluoview Upright
Confocal microscope using a sequential laser scanning
protocol.
Viral growth assays
H1299 cells grown to 30% conﬂuency were transfected
with 100nM of either siEGFP (50-GCAACGUGACCC
UGAAGUUCdTdT-30) or siMadp1 (50-CAAUGACUU
GUACCGGAUAdTdT-30) using DharmaFECT 2
siRNA Transfection Reagent (Dharmacon) for 72h.
Cells were infected with recombinant IBV-Luc at a multi-
plicity of infectivity of  1 (MOI & 1) and incubated for
2h at 37 C, 5% CO2. The virus-containing medium was
replaced with fresh serum-free medium and the cells were
either harvested immediately (0h) or continued to be
incubated at 37 C until speciﬁc time points post infection
(4, 8, 12, 16, 20 or 24h). Infected cells were subjected to
lysis, either through three freeze–thaw cycles (at  80 C
and room temperature, respectively) without removal of
media, or using lysis buffer after removal of media. Fireﬂy
luciferase activity which was used as an indication of viral
activity for the recombinant virus was measured using
Luciferase Assay System (Promega) according to manu-
facturer’s instructions using the cell lysates. An end-point
dilution assay, the 50% tissue culture infectious dose
(TCID50), the amount of virus that will produce
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the infected cells was used as a measurement of virus titer.
The TCID50 of the infected cells at each time point was
determined by using the freeze–thawed infected cells. For
each sample, a 10-fold serial dilution was performed and
ﬁve wells of Vero cells on 96-well plates were infected with
each dilution. The numbers of infected wells were collated
and TCID50 of each sample was calculated using the
Reed–Muench method (5).
Reverse transcription-polymerase chain reaction
determination of the replication and sub-genomic
transcription efﬁciency of IBV
Total RNAs were prepared from the infected cells at their
speciﬁed time points using Trizol Reagent (Invitrogen)
Reverse transcription (RT) was performed with Expand
reverse transcriptase (Roche) according to the manufac-
turer’s instructions using the sense primer IBV leader
(50-26CTATTACACTAGCCTTGCGCT46-30) for the de-
tection of negative-stranded subgenomic RNA (sgRNA)
and the antisense primer IBV24803-R (50-24803CTCTGG
ATCCAATAACCTAC24784-30) for the detection of
positive-stranded sgRNA. Both primers were then used
for PCR. If transcription of subgenomic mRNAs did
occur, a 415-bp PCR product corresponding to the
50-terminal region of subgenomic mRNA 5 and a 648-bp
fragment corresponding to the 50-terminal region of
subgenomic mRNA 4 would be expected. Similarly,
RT was carried out with the sense primer IBV14931-F
(50-14931GCTTATCCACTAGTACATC14949-30) for
the detection of negative-stranded genomic RNA. Sense
primer IBV14931-F and the antisense primer IBV15600-R
(50-15600CTTCTCGCACTTCTGCACTAGCA15578-30)
were used for PCR. If replication of viral RNA occurred,
a 670-bp PCR fragment would be expected.
Construction and selection of stable knockdown cell lines
Oligonucleotides were designed based on siMadp1
sequence and cloned into pSilencer 2.1 Neo (Ambion) ac-
cording to manufacturer’s instructions. Negative control
silencer construct was supplied with the cloning kit.
Constructs pSilencer-NC (negative control) and
pSilencer-Madp1 were transfected into H1299 cells
with Effectene Transfection Reagent. Transfected cells
were selected with 500mg/ml G418 (Sigma) and the
selected clones were subjected to screening for MADP1
knockdown efﬁciency. Selected H1299-shNC and H1299-
shMadp1 stable cell lines were maintained in media con-
taining 500mg/ml of G418.
RESULTS
Yeast three-hybrid screening for human proteins that
could interact with SARS-CoV UTRs
In order to ﬁnd candidate host proteins that may be
involved in the replication and transcription of corona-
virus RNA, a yeast-based three-hybrid (34) screen
against a human cDNA library using the 50-UTR of
SARS-CoV RNA as bait was performed. Screens were
also performed using the negative sense 50-UTR and
30-UTR as bait. Each screen yielded about six to eight
colonies which were sequenced and non-sense sequences
of the candidates were eliminated. In total, the screen
identiﬁed three candidates, MADP1, HAX1 and riboso-
mal protein L27a as binding partners to SARS-CoV
positive sense 50-UTR, negative sense 50-UTR and
negative sense 30-UTR, respectively. Although it was inter-
esting to ﬁnd ribosomal protein L27a interacting with the
Table 1. Nucleotide sequences of primers used to amplify DNA templates for in vitro transcription
Primer name Sequence
T7_i1-27 50-TGTAATACGACTCACTATAGGACTTAAGATAGATATTAATATATATCT-30
pT_i507-528R 50-TTTTTTTTTTTTTTTTTTTTTGTTGTCACTGTCTATTGTATGT-30
T7_i528-506 50-TGTAATACGACTCACTATAGGGTTGTCACTGTCTATTGTATGTC-30
pT_i1-29 50-TTTTTTTTTTTTTTTTTTTTTACTTAAGATAGATATTAATATATATGTAT-30
T7_i30-51 50-TGTAATACGACTCACTATAGGTACACTAGCCTTGCGCTAGATT-30
pT_i99-80 50-TTTTTTTTTTTTTTTTTTTTTCCTATGAGGACCAGCTGTAG-30
T7_i141-162 50-TGTAATACGACTCACTATAGGGCCACCTGTCAGGTTTTTGTTA-30
pT_i140-121 5’-TTTTTTTTTTTTTTTTTTTTTCAGGTGCCATCCAGGGCACT-30
T7_i1-27_SL1dsmut 50-TGTAATACGACTGAGTATAGGACTTAAGATACTTATTAATATATATGT-30
T7_i1-26_SL1rsmut 50-TGTAATACGACTCACTATAGGACTTAAGATACTTATTAATATATAAG-3’
pT_EGFP_F 50-TTTTTTTTTTTTTTTTTTTTTATGGTGAGCAAGGGCGAGG-30
T7_EGFP_510-528R 50-TGTAATACGACTCACTATAGGGCTGCCGTCCTCGATGTTG-30
T7_i27106-27125 50-TGTAATACGACTCACTATAGGGTAACATAATGGACCTGTTG-30
LDX30 50-TGATGCCGGCCACGATGCGTC-30
Table 2. Primer pairs used in ampliﬁcation of DNA templates for
in vitro transcription
Fragment Sense primer Anti-sense primer
IBV 50-UTR (+) T7_i1-27 pT_i507-528R
50-UTR 1 T7_i1-27 pT_i140-121
50-UTR 2 T7_i1-27 pT_i99-80
50-UTR 3 T7_i30-51 pT_140-121
50-UTR 4 T7_141-162 pT_i507-528R
50-UTR 2M1 T7_i1-27_SL1dsmut pT_i99-80
50-UTR 2M2 T7_i1-26_SL1rsmut pT_i99-80
IBV 30-UTR T7_i27106-27125 LDX30
EGFP T7_EGFP_510-528R pT_EGFP_F
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protein translation, subsequent functional studies of the
protein would prove to be complicated as the virus itself
relies heavily on the host ribosome to translate viral
proteins, necessary for the infection to proceed.
Therefore, it was not chosen for further studies. HAX1
was reported to function as an anti-apoptotic protein,
which was not the focus of our screen and was therefore
not chosen for further studies as well. MADP1 was
reported as a member of the alternative splicing
pathway, which implied a possible role in facilitating
distal RNA sequences to be brought into close proximity,
corresponded well with current evidence on the mechan-
ism of discontinuous transcription. Therefore, it was
chosen as the sole target for this study.
The 50-UTR of coronavirus genomic RNA interacts
speciﬁcally with MADP1
The interaction between MADP1 and the coronavirus
50-UTR was conﬁrmed by using over-expressed
Flag-tagged MADP1 in a biotin-RNA pull-down assay.
Based on the efﬁciency of Flag-tagged MADP1
co-puriﬁcation with the biotinylated RNA, the full-length,
mammalian-expressed MADP1 was found to be able to
interact with the 50-UTR of IBV and SARS-CoV RNA
(Figure 1A). Over-expressed Flag-tagged protein was used
to facilitate detection, as there was no commercially avail-
able antibody to the protein at that time. It was noted that
IBV 50-UTR showed higher binding afﬁnity to the
Flag-tagged MADP1 than did SARS-CoV 50-UTR
(Figure 1A). The speciﬁc interaction between IBV
50-UTR and MADP1 and its functional implication in
coronavirus replication were therefore chosen for subse-
quent characterization.
To check the speciﬁcity of the interaction, a competition
assay based on the biotin-RNA pull-down assay was per-
formed. Total cell lysates containing Flag-tagged MADP1
were incubated with 0.1mM biotinylated IBV 50-UTR in
the presence of increasing concentrations of either un-
labeled speciﬁc competitor RNA probe (IBV 50-UTR) or
unlabeled non-speciﬁc probe (EGFP RNA) composed
of nucleotides 1–528 of the EGFP coding sequence,
from 0 to 0.2mM. Western blot analysis of the co-puriﬁed
Figure 1. MADP1 interacts speciﬁcally with IBV 50-UTR.(A) Interaction of MADP1 with SARS-CoV and IBV 50-UTR in a biotin-RNA pull-down
assay. Total cell lysates prepared from H1299 cells over-expressing Flag-tagged MADP1 were mixed with 0.1mM of biotinylated IBV and SARS-CoV
50-UTR, respectively, followed by addition of streptavidin agarose beads. Unbound complexes to the beads were subsequently removed by washing
and complexes that remained bound to the beads were eluted with gel loading buffer. All fractions and elute were resolved by SDS–PAGE and
probed with antibody to Flag tag. (B) Competition assay for the speciﬁcity of interaction between MADP1 and IBV 50-UTR. Total cell lysates
prepared from H1299 cells over-expressing Flag-tagged MADP1 was added to mixtures of 0.1mM biotinylated IBV 50-UTR RNA and varying
concentrations of unlabeled IBV 50-UTR or EGFP RNA. Streptavidin agarose beads were added and treated under conditions identical to (A). Total
cell lysates prepared from cells over-expressing Flag-tagged IBV N protein were added to mixtures of a ﬁxed concentration of biotinylated IBV
30-UTR RNA and unlabeled IBV 30-UTR or EGFP RNA and subjected to the same treatment.
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tions of unlabeled speciﬁc competitor RNA led to the
decreasing co-puriﬁcation of MADP1 with the
biotinylated RNA probe (Figure 1B). However, increasing
concentrations of unlabeled non-speciﬁc competitor RNA
did not result in detectable change to the efﬁciency of
MADP1 co-puriﬁcation (Figure 1B).
Simultaneously, a protein exhibiting a non-speciﬁc
RNA-binding activity, the Flag-tagged IBV-N, was used
as a control. Total cell lysates containing the Flag-tagged
IBV N protein was incubated with 0.1mM of the
biotinylated IBV 30-UTR, in the presence of increasing
concentrations of either the unlabeled speciﬁc probe or
an unlabeled non-speciﬁc probe, EGFP RNA, of an
equal length. Western blot detection of the co-puriﬁed
Flag-tagged N protein revealed that increasing concentra-
tions of both unlabeled RNA probes increasingly reduced
the efﬁciency of N protein co-puriﬁcation with the
biotinylated RNA probes (Figure 1B). These results con-
ﬁrmed that MADP1 could interact speciﬁcally with the
50-UTR of IBV RNA.
Over-expressed Flag-tagged MADP1 translocates from
the nucleus to the cytoplasm
MADP1 was identiﬁed as a component of the 18S U11/12
snRNP (37) and its subcellular localization was
determined to be in the nucleoplasm (35). IBV replication
and transcription, on the other hand, take place in the
cytoplasm of the infected cells. Therefore, to validate the
likelihood of MADP1 interacting with the viral 50-UTR,
immunoﬂuorescence was used to track the subcellular lo-
calization of both Flag-tagged MADP1 and de novo
synthesized viral RNA in both mock-infected and
IBV-infected cells. Flag-tagged MADP1 was over-
expressed in cultured Vero cells, which were then
infected with IBV and treated with actinomycin D to
inhibit host transcription. The newly synthesized viral
RNA, a marker for the RTCs, was labeled with BrUTP.
The cells were ﬁxed at 10h post-infection to allow sufﬁ-
cient labeling of the newly synthesized viral RNA and to
minimize the formation of large syncytial cells. In unin-
fected cells, Flag-tagged MADP1 was localized in the
nucleus exclusively (Figure 2). Upon infection by IBV,
Flag-tagged MADP1 appeared to be present in the cyto-
plasm as well (Figure 2). Interestingly, the cytoplasmic
localization pattern of Flag-tagged MADP1 appears
to be partially overlapped with that for the RTCs,
although further studies would be required to ascertain
if MADP1 would be a part of the RTCs (Figure 2).
As a negative control for the over-expressed protein,
vector transfected cells probed with Flag antibody
showed negative staining for the over-expressed protein
(Figure 2). Similar colocalization patterns were also
observed in IBV-infected H1299 cells (Figure 2).
Figure 2. Over-expressed Flag-tagged MADP1 partially colocalized with viral RTCs. Vero cells over-expressing either Flag-tagged MADP1 or empty
vector were infected with IBV, treated with actinomycin D at 3h post-infection, and transfected with bromo-UTP at 7h post-infection. Cells were
ﬁxed at 10h post-infection and permeabilized with Triton-X 100. Immunoﬂuorescence was performed with antibodies to Flag and BrdU followed by
secondary antibodies conjugated with Alexa Fluor 488 and 594, respectively. Vector-transfected Vero cells infected with IBV were used as negative
controls. H122 cells transfected with Flag-tagged MADP1 and infected with IBV, as described for Vero cells.
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with MADP1
To deﬁne the segment and structural elements of IBV
50-UTR required for its interaction with MADP1, four
truncated mutant RNA fragments were synthesized, as
shown in Figure 3A, by in vitro transcription. 50-UTR 1
contains stem–loops I–IV (38), 50-UTR 2 and 50-UTR 3
spans stem–loops I to III and II to IV, respectively,
whereas 50-UTR 4 spans the rest of the 388 nucleotides.
The biotin-labeled RNA transcripts were used in the
biotin-RNA pull-down assay (Figure 3B) to check the
efﬁciency of Flag-tagged MADP1 co-puriﬁcation with
RNA. Results showed that MADP1 was co-puriﬁed
only with transcripts which contain stem–loops I–III of
the 50-UTR (50-UTR 1 and 50-UTR 2). In addition,
stem–loop I appeared to be essential for interacting with
MADP1 as its absence in 50-UTR 3 abolished the inter-
action with MADP1 (Figure 3B). The rest region of the
50-UTR (50-UTR 4) did not appear to interact with
MADP1 (Figure 3B).
To conﬁrm further the role of stem–loop I in the inter-
action between MADP1 and IBV 50-UTR, two mutants
were constructed, based on 50-UTR 2. 50-UTR 2M1
carried two-point mutations at nucleotide residues 11
and 12 from GA to CU, which would disrupt the structure
of stem–loop I (Figure 3C), and 50-UTR 2M2 carried
additional mutations at residues 25 and 26 from UC to
AG (Figure 3C), which would restore the secondary struc-
ture of stem–loop I. The mutant RNAs spanning stem–
loops I–III were assessed for its ability to bind MADP1.
The result indicated that the integrity of stem–loop I may
be essential for the interaction between the 50-UTR with
MADP1 (Figure 3D), as the stem–loop disrupting
mutation (50-UTR 2M1) failed to interact with
MADP1. The stem–loop restoring mutation at nucleotide
residues 25 and 26 from UC to AG was able to restore
partially the interaction (50-UTR 2M2) (Figure 3D). This
result afﬁrmed the conclusion that the secondary structure
of stem–loop I of IBV 50-UTR is indispensable for its
interaction with MADP1.
The RNA recognition motif (RRM) of MADP1 is
responsible for its interaction with IBV 50-UTR
MADP1 contains two nucleic acid binding domains, the
RNA recognition motif (RRM) in the N-terminal region
and the universal minicircle sequence binding protein
(UMSBP) in the central region. In order to identify the
domain involved in the interaction between MADP1 and
IBV 50-UTR, a series of truncation mutants of the protein
were created (Figure 4A). The ﬁrst three mutants,
Madp1n which contains the RRM domain, Madp1m
spans the zinc ﬁnger domain and Madp1c contains
mostly phosphorylation sites, were assessed for their
ability to interact with IBV 50-UTR. Only Madp1n
Figure 3. Deﬁning the protein interaction sequence. (A) A schematic diagram of the RNA probes used to deﬁne the interaction region. Numbers
denote nucleic acid residue position and roman numerals denote stem–loop number. The boundary of the leader sequence of IBV (nt. 1–64) is
marked by the box on the full-length 50-UTR. (B) Interaction of various deletion constructs of IBV 50-UTR with MADP1. Total cell lysates prepared
from H1299 cells over-expressing Flag-tagged MADP1 were mixed with RNA probes spanning different regions of IBV 50-UTR. The RNA–protein
complexes were puriﬁed with streptavidin beads, resolved by SDS–PAGE and probed with antibody to Flag tag for the presence of Flag-tagged
MADP1 protein. (C) Diagram showing the two mutants of 50-UTR 2 containing either two point mutations which disrupt stem–loop I
(50-UTR 2M1) or a mutant restoring stem–loop I in 50-UTR 2M1 (50-UTR 2M2). (D) The essential role of a stem–loop I in the interaction
between MADP1 and IBV 50-UTR. Total cell lysates prepared from H1299 cells over-expressing Flag-tagged MADP1 were mixed with
50-UTR 2M1 and 50-UTR 2M2, respectively. The RNA–protein complexes were puriﬁed with streptavidin beads, resolved by SDS–PAGE and
probed with antibody to Flag tag for the presence of Flag-tagged MADP1 protein.
5070 Nucleic Acids Research, 2012,Vol.40, No. 11retained a low level of the RNA-binding activity
(Figure 4B, 1n) and negligible activity was detected for
the other two truncated proteins (Figure 4B, 1m, 1c).
As the RNA-binding activity for Madp1n fragment was
much lower compared to the full-length protein, three
more mutants were created to extend the Madp1n
fragment (Figure 4A). An extension of 14 or 31 amino
acid residues was made for mutants Madp1x and
Madp1z, respectively. A truncation at the N-terminus by
40 residues as well as an extension by 14 amino acid
residues was made for Madp1y. It was observed that
both Madp1x and Madp1z bound to IBV 50-UTR more
strongly than did the full-length protein as well as
Madp1n mutant protein (Figure 4B, 1x, 1z). Madp1y,
on the other hand, bound weakly to the RNA fragment
(Figure 4B, 1y). Hence, the 14 amino acid extension
beyond the RRM (Madp1x) may have been required to
preserve the integrity of the protein structure and that the
40 amino acid residues at the N-terminus of MADP1 are
required for efﬁcient RNA binding.
As the RRM domain was determined to be responsible
for the interaction, information available on this domain
indicated three amino acids at its active site, which interact
with nucleic acid residues via their aromatic and hydro-
phobic side chains. For MADP1, the identiﬁed active site
was composed of phenylalanine 55 and valine 53, respect-
ively, while tyrosine 13 may have acted as an anchor for
the phosphate backbone via electrostatic interactions.
Hence, three mutants with either a single alanine substi-
tution for tyrosine 13 (Y13A), a double alanine substitu-
tion for valine 53 and phenylalanine 55 (V53F55A) or
triple alanine substitutions for all three residues (YVF),
were constructed (Figure 4A). These three mutants were
over-expressed in H1299 cells as Flag-tagged proteins, and
the lysates were assessed for their respective RNA-binding
afﬁnities for full-length IBV 50-UTR (Figure 4C).
Figure 4. Deﬁning the RNA-binding domain. (A) A schematic diagram of constructs of MADP1 and its truncation mutants. Numbers denote amino
acid residue positions. Conserved domains RNA Recognition Motif (RRM) and Universal Minicircle Sequence Binding Protein (UMSBP) were
indicated as black and white blocks, respectively. (B) Interaction of deletion mutants of MADP1 with IBV 50-UTR. Cell lysates prepared from H1299
cells over-expressing Flag-tagged wild-type MADP1 or its truncation mutants were used for biotin-RNA pull-down assay using the full-length IBV
50-UTR. Both the crude lysates (labeled C) and protein bound on the streptavidin beads (labeled E) were resolved by SDS–PAGE and detected by
Western blot with anti-Flag antibody. EGFP over-expressed cell lysate was included as a negative control. (C) Interaction of three MADP1 mutant
constructs, Y13A, V53F55A and YVF, with IBV 50-UTR. The three full-length MADP1 constructs with amino acid mutations at the predicted
RNA-binding sites were transfected into H1299 cells and used in a biotin-RNA pull-down assay with the full-length IBV 50-UTR.
Nucleic Acids Research, 2012,Vol.40, No. 11 5071All mutants resulted in a reduction in RNA-binding
afﬁnity for the biotinylated RNA molecule and the reduc-
tion was most dramatic for triple residue mutant YVF
(Figure 4C), implying cooperative binding demonstrated
by the three residues. This ﬁnding conﬁrms that the
MADP1 RRM is involved in the interaction with IBV
50-UTR.
MADP1 is required for efﬁcient virus transcription
To demonstrate the signiﬁcance of the interaction between
MADP1 and IBV 50-UTR, an siRNA duplex designed to
silence MADP1 expression (siMadp1) and a negative
control siRNA targeting EGFP protein (siEGFP) were
used in time course experiments. H1299 cells were trans-
fected twice with the siRNA duplexes in 24-h interval and
infected with IBV-Luc recombinant virus (39) 3 days after
the ﬁrst transfection. IBV-infected samples were harvested
at 0, 4, 8, 12, 16, 20 and 24h post-infection, respectively,
and the mock-infected cells were harvested at 24h
post-infection as a negative control. The levels of
negative stranded genomic RNA and both the positive
and negative stranded subgenomic RNA were assessed by
RT-PCR (Figure 5A). Densitometric analyses identiﬁed a
reduction between 40% and 80% of MADP1 mRNA was
achieved by this siRNA which resulted in a reduction
between 70% and 90% of negative stranded genomic
viral RNA, 40–80% of negative stranded subgenomic
viral RNA and 50–90% of positive stranded subge-
nomic viral RNA.
Western blot analysis also noted a reduction in the
expression of viral structural genes, between 50% and
90% reduction for S and N proteins, with a reduction
between 40% and 80% of MADP1 protein (Figure 5B).
Virus titers as represented by the tissue culture infectious
dose (Log10 TCID50) at each infection time point
was reduced by a minimum of 3-fold and up to 10-fold
compared to siEGFP-transfected cells beyond 4h of
infection (Figure 5C). Fireﬂy luciferase activity of cell
lysates harvested at different time points showed a
minimum of 50% reduction upon the silencing of
MADP1, which supports further the observation that
the total viral protein production was much reduced
(Figure 5D).
To eliminate the possibility that the phenotype observed
in MADP1-silenced cells during IBV infection was due to
an off-target effect of the siRNA duplex used, four add-
itional siRNA duplexes targeting different regions of
MADP1 were used in various combinations with
siMadp1 (Figure 6) to check their effect on IBV infection,
as illustrated by the expression of the luciferase gene
(Figure 6B). All six combinations of ﬁve different
siRNA duplexes resulted in a reduction in the luciferase
activity of the infected cells by either 70% (siCombi 3
and 4), without siMadp1 or more than 90% (siCombi 1,
2, 5 and 6) with siMadp1, compared to negative control,
siEGFP-transfected cells (Figure 6B). This implies that, in
general, knocking down MADP1 with any siRNA results
in a reduction of virus infection.
Expression of a silencing-resistant mutant MADP1 in a
stable MADP1-knockdown cell clone enhances IBV
replication
A stable cell clone expressing short hairpin RNA to
MADP1 (shMadp1) was selected from H1299 cells and
the madp1 mRNA level was conﬁrmed using northern
blot (Figure 7A). The expression of MADP1 and the
effect of MADP1-knockdown on IBV infection were
tested by comparing with a G418-selected cell line
without expression of shMadp1 (non-targeting control,
shNC). The results showed that, in general, silencing of
MADP1 with shRNA reduced the amount of viral mRNA
production before 16h post-infection (Figure 7B). The
amount of virus mRNA is higher in shMadp1 cells
compared to shNC cells beyond 16h of infection as infec-
tion in shNC cells progressed much faster and most cells
died and detached (Figure 7B).
The shMadp1 cell line was then transfected with con-
structs expressing Flag-tagged wild type MADP1 (FM),
triple residue mutant (FM(YVF)), two mRNA mutants
resistant to silencing by siMadp1 based on wild-type
MADP1 (FMmut) and the triple residue mutant
(FMmut(YVF)), negative vector control (F) and EGFP
(E), respectively. The two siRNA-resistant mutants were
constructed by mutating the siRNA-targeting sequence
with degenerate codons, so that the protein sequence of
MADP1 was maintained. These transfected cells were sub-
sequently infected with IBV-Luc and harvested at 19h
post-infection. Western blotting results showed an
obvious increase in the amount of IBV N expression in
cells over-expressing silencing-resistant wild-type MADP1
(FMmut) as well as a slight increase in cells over-expressing
both normal triple residue mutant (FM(YVF)) and
silencing-resistant triple residue mutant (FMmut(YVF))
(Figure 7C).
An assessment of the luciferase activity of total cell
lysates showed that over-expression of triple residue
mutants FM(YVF) and FMmut(YVF) resulted in a
slight increase of the luciferase activity in shMadp1 cells,
whereas over-expression of silencing-resistant wild-type
MADP1 (FMmut) resulted in a more drastic increase of
the luciferase activity in shMadp1 cells (Figure 7D).
MADP1 interacts weakly with human coronavirus
OC43 (HCoV-OC43) 50-UTR
It was noted that although MADP1 interacted with both
SARS-CoV and IBV 50-UTR, the interaction was rather
weak for the former. A comparison of the predicted stem–
loop I structures from both coronaviruses indicated a
marked difference in their primary sequence as well as
the secondary structures. Hence, a third coronavirus,
HCoV-OC43, whose stem–loop I which deviated further
from IBV than SARS-CoV, was assessed for its binding to
MADP1 (Figure 8A). It was found that the binding of
MADP1 to the 50 UTR of HCoV-OC43 was as weak, if
not weaker than SARS-CoV. It was also noted that the
predicted stem–loop I structure of HCoV-OC43 contained
a bulge which encompassed a larger area of the stem
compared to SARS-CoV (Figure 8B). Bulges were con-
spicuously absent from the IBV stem–loop I (Figure 8B).
5072 Nucleic Acids Research, 2012,Vol.40, No. 11Figure 6. Two hundred and ﬁfty pico moles (250pmol) of either siRNA to EGFP or siRNA pools against Madp1 were transfected into H1299 cells
twice and infected with recombinant luciferase-IBV at 72h after the ﬁrst transfection. (A) Volumes (in microliters) of each 50-mM siRNA used in the
siRNA pools. (B) Luciferase activity of the infected cells measured at 20h post-infection showed a decrease in viral activity after silencing Madp1
with the different siRNA pools.
Figure 5. Knockdown of MADP1 by siRNA suppresses IBV infection. (A) RT-PCR analysis of the effect of MADP1 knockdown on IBV RNA
replication. H1299 cells were transfected twice with siRNA targeting either Madp1 (+siMadp1) or EGFP (–siMadp1) and infected with IBV-Luc
recombinant virus 3 days after the ﬁrst transfection. Samples were harvested at 4-h intervals, and mock-infected cells were used as negative control.
RT-PCR analyses of the mRNA levels of MADP1, the negative strand IBV RNA (gRNA(-)), (+) and (–) mRNAs 3 and 4 (sgRNA) and control
GAPDH were carried out. (B) Western blot analyses of the protein levels of Madp-1, viral proteins spike (S), nucleocapsid (N) and cellular protein
actin for loading control. (C) TCID50 of total virus produced by the virus-infected cells showed that the silencing of Madp1 reduced virus titers by
several folds. (D) Luciferase gene activity measured for the cell lysate indicated a dramatic drop in viral activity in the Madp1 silenced H1299 cells.
Nucleic Acids Research, 2012,Vol.40, No. 11 5073In addition to the differences in the secondary structures
between the coronaviruses, there was a lack of sequence
similarity as well (Figure 8B).
DISCUSSION
Previous studies on the involvement of host proteins in
viral RNA synthesis have revealed a number of proteins
which are able to interact with the UTRs of viral genomes
(29,30,32,40–43). Some of these proteins may also interact
with other viral proteins as well (30,40). Our attempts to
identify host proteins involved in this early process of the
coronavirus life cycle yielded MADP1. This protein was
shown to be localized to the nucleoplasm but excluded
from the nucleolus, but its role in RNA splicing remains
to be determined (37). MADP1 contains two conserved
RNA-binding domains, the RNA recognition motif
(RRM) 1 and universal minicircle sequence binding
protein (UMSBP) domains (a zinc ﬁnger CCHC-type)
(35). The former was determined to be the domain respon-
sible for the interaction between MADP1 and IBV
50-UTR. The MADP1 RRM 1 domain interacts with
nucleic acid residues via aromatic and hydrophobic side
chains at its active site, which in the case supplied by
phenylalanine 55 and valine 53, respectively. Tyrosine 13
may have acted as an anchor for the phosphate backbone
via electrostatic interactions.
In this study, interaction between MADP1 and the
SARS-CoV and IBV 50-UTR was initially identiﬁed by a
yeast-based three hybrid screen and subsequently con-
ﬁrmed using an in vitro RNA pull-down assay with IBV
50-UTR. A deeper look at the details of this interaction
revealed that the RNA recognition motif, but not the zinc
ﬁnger motif, of MADP1, is responsible for the interaction.
This interaction is also shown to be speciﬁc and stem–loop
I of IBV 50-UTR is essential for the interaction to occur.
Although MADP1 was reported to be a nuclear protein
(35), it could be detected in the cytoplasm of IBV-infected
cells and partially overlaps with the de novo synthesized
viral RNA, which marks the location of the RTCs in
infected cells in the presence of actinomycin D. Silencing
of MADP1 resulted in a marked reduction in syncytium
formation upon IBV infection. A closer examination
revealed that the synthesis of both genome- (gRNA) and
Figure 7. Over-expression of siRNA-resistant MADP1 enhances IBV replication in stable MADP1-knockdown cells. (A) Northern blot analysis of
H1299 cells stably transfected with either negative control shRNA (shNC) or short hairpin RNA to MADP1 (shMadp1). Total RNA was prepared
from the two G418-selected stable clones and separated on 1% agarose gel and probed by a Dig-labeled speciﬁc MADP1probe. (B) Northern blot
analysis of IBV RNAs in IBV-infected shNC and shMadp1 stable clones. Cells were infected with IBV-Luc at a multiplicity of  1, harvested at 0, 8,
10, 12, 14, 16 and 20h post-infection, respectively. Total RNA was prepared, separated on 1% agarose gel and probed by a Dig-labeled speciﬁc
probe. (C) Western blot analysis of IBV N protein expression in IBV-infected siMadp1 cells transfected with wild-type or mutant MADP1. shMadp1
stable cell clone was transfected with constructs expressing Flag-tagged wild-type MADP1 (FM) and its triple mutant [FM(YVF)], siRNA-resistant
MADP1 (FMmut) and its triple mutant [FMmut(YVF)], negative controls EGFP (E), and empty vector control (F), respectively, using
Lipofectamine 2000 (Invitrogen). Cells were then infected with IBV-Luc virus at a multiplicity of  1, and harvested at 19h post-infection for
western blot. Over-expressed Madp1 and IBV N were detected with speciﬁc antibodies, and actin was detected with a commercial antibody as a
loading (Santa Cruz). (D) Fireﬂy luciferase activities of cell lysates from above were normalized against vector-transfected control (F, treated as
100%), and expressed as a percentage to that in the control cells.
5074 Nucleic Acids Research, 2012,Vol.40, No. 11subgenome-length RNAs (sgRNA) was compromised,
resulting in a drastic reduction of viral structural protein
expression and release of viral progeny (titers), hence the
overall reduction of viral infectivity in the cells.
Across different coronaviruses, the leader sequence
situated in the extreme 50 end of the genome, is
composed of stem–loops I and II. Mutations introduced
into either stem–loop I or II resulted in non-viable viruses,
impaired (sense and anti-sense) sgRNA synthesis, but not
the full-length gRNA synthesis (38,44). It was, however,
observed in this study that silencing of MADP1 did render
an impact on gRNA synthesis, although to a lesser extent
compared to sgRNA synthesis. This might have been due
to a secondary effect of decreased sgRNA synthesis, as
proteins encoded by sgRNAs may enhance viral RNA
synthesis (45). The predicted structure of stem–loop II
indicated a strong secondary interaction, which is highly
conserved across different groups of coronaviruses. The
predicted stem–loop I structure, on the other hand,
appears to fold into a hairpin of low thermodynamic sta-
bility, shows a wider sequence variation and is
characterized by the presence of bulges, non-canonical
base pairing as well as a prevalence of A-U base pairing
(46). It has been shown in MHV that the structural liabil-
ity of stem–loop I is a critical driving force in the 50- and
30-UTR interaction (44). Comparing the predicted stem–
loop I structures of IBV to SARS-CoV and HCoV-OC43
(Figure 8B), it was noted that there exists a difference in
the loop sequence. In addition, IBV stem–loop I has a
shorter stem and the absence of bulges, although the
structure may be as unstable thermodynamically as that
of SARS-CoV and HCoV-OC43, due to the extremely
high prevalence of weak base pairing between A and U
as well as the presence of a non-canonical base pair at the
base of the stem (46). Hence, sequence and structural dif-
ferences may be one of the possible explanations for the
observation of a weaker binding between MADP1
and SARS-CoV or HCoV-OC43 50-UTR than
with IBV 50-UTR. In fact, the relatively weaker binding
of MADP1 to the stem–loop I restoring mutant
(50-UTR 2M2) demonstrated in this study supports that
primary sequences in the 50-UTR may play a certain role
in this interaction.
Most studies on host involvement in coronaviral RNA
synthesis were so far performed using MHV (29–31,42,43).
Identiﬁcation of the interaction between MADP1 and
50-UTR as well as its functional involvement in corona-
virus replication, in this study, therefore may represent the
ﬁrst host protein identiﬁed to play a role in viral RNA
synthesis by interacting with the 50-UTR of the viral RNA
in a gammacoronavirus. The functional implication of the
interaction between MADP1 and IBV 50-UTR may be
extended to the rest of the members of the coronavirus
family. In the case of hnRNP A1, it was initially
reported to be functionally important for viral RNA syn-
thesis for group II virus MHV (29,30). Subsequently, its
involvement in viral RNA synthesis was also conﬁrmed in
TGEV, a group I coronavirus (32). In this study, we have
shown that betacoronaviruses HCoV-OC43, SARS-CoV
and gammacoronavirus IBV can bind to MADP1, albeit
Figure 8. Comparison of the 50 UTR of IBV, SARS-CoV and HCoV-OC43. (A) Interaction of the 50 UTR from IBV, SARS-CoV and HCoV-OC43
with MADP1. Total cell lysates prepared from H1299 cells over-expressing Flag-tagged MADP1 were mixed with biotinylated RNA probes of
full-length 50 UTRs of the three coronaviruses. The RNA–protein complexes were puriﬁed with streptavidin beads, resolved by SDS–PAGE and
probed with antibody to Flag tag for the presence of Flag-tagged MADP1 protein. (B) The predicted secondary structures of stem–loop I from IBV,
SARS-CoV and HCoV-OC43.
Nucleic Acids Research, 2012,Vol.40, No. 11 5075with different afﬁnities. Due to the lack of a high contain-
ment facility, the functional implication of the relatively
weaker interaction between SARS-CoV 50-UTR and
MADP1 was not further studied. It is, therefore, yet to
be demonstrated if this weaker binding dictates less
dependency on MADP1 in SARS-CoV RNA replication
and infectivity.
Current evidence indicates that MADP1 is
compartmentalized in the nuclei of cultured cells (35),
markedly differing from the cytoplasmic, perinuclear
localization of the coronavirus RTCs (47–49). As there
was no report on the possibility of MADP1 shuttling
between the nucleus and cytoplasm, our observation
using indirect immunoﬂuorescence that over-expressed
MADP1 upon IBV infection became partially localized
in the cytoplasm may represent a ﬁrst report that
MADP1 could be localized outside the nucleus. This
could have been achieved with either an existing shuttling
mechanism used by a nuclear protein or the assistance of
viral factors. For example, IBV N protein is known to
enter the nucleus while maintaining a predominantly cyto-
plasmic localization (50,51). Alternatively, binding of viral
RNA may partially retain the newly synthesized MADP1
in the cytoplasm, as observed in this study.
It was observed that over-expression of Flag-tagged
MADP1 was unable to fully restore IBV infection in
MADP1-knockdown cells, even though the expression
level of the introduced MADP1 construct far surpassed
the endogenous level, as observed by western blot
analysis. Considering the fact that only 30% of cells
were transfected and over-expressed MADP1 protein
despite the presence of a higher level of the protein
in the transfected cells, it is understandable that the ex-
pression of viral proteins could not be restored
after combining both transfected and untransfected cells.
Interestingly, over-expression of silencing-sensitive
MADP1 was unable to cause an increase in virus infec-
tion, comparing to that was observed for silencing-
resistant MADP1 (FMmut) in shMadp1 cells, even
though their expression levels were comparable. This
lends further support to the conclusion that MADP1 is
actively involved in the replication and infectivity of IBV.
Although the functional studies involving IBV, a
chicken coronavirus, and a human protein, MADP1,
were conducted using human and African green monkey
cells, which were non-native. It is noteworthy that
MADP1 (HomoloGene 12095) is conserved in humans
(Homo sapiens), chimpanzees (Pan troglodytes), wolves
(Canis lupus), cattle (Bos Taurus), mice (Mus musculus),
rats (Rattus norvegicus) and chickens (Gallus gallus). The
African green monkey genome is not available at NCBI,
but an alignment search using basic local alignment search
tool (BLAST) of the MADP1 amino acid sequence against
the rhesus macaque (Macaca mulatta) RefSeq Protein
library yields a 99% sequence similarity between the two
species. The chicken homolog, on the other hand, bears
85% amino acid sequence similarity, but with an almost
identical match in the N-terminal 120 amino acids, to the
human MADP1 protein. As the predicted interaction
domain lies in the N-terminus, it is highly likely that the
homologs from other species could replace human
MADP1 in the interaction studies.
In conclusion, the involvement of MADP1 in corona-
virus RNA synthesis and its signiﬁcance are demonstrated
in this study in the tissue culture system. Further studies
with an MADP1 knock-out animal system, which is cur-
rently not available, would be required to conﬁrm further
the involvement of MADP1 in coronavirus RNA
synthesis.
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